Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

DARPA awards fourth milestone payment of $3.56M to Medicago

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.

13 Feb 2012

First Edition: February 13, 2012

Today's early morning highlights from the major news organizations preview President Barack Obama's budget, which will be released today, and examine the lingering controversy over mandates on contraceptive coverage.

13 Feb 2012

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.

13 Feb 2012

WHO convening meeting in one week to explore opinions surrounding H5N1 bird flu research

NPR's health blog "Shots" previews an upcoming WHO-convened meeting to discuss the recent news that two research teams have created H5N1 bird flu strains that are easily transmissible among ferrets, which are used as lab models for humans.

13 Feb 2012

Grand Challenges Canada, Gates Foundation announce grants for innovative Global Health projects

"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.

13 Feb 2012

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."

10 Feb 2012

Forsyth Institute to receive TB biomarkers grant from Gates Foundation

The Forsyth Institute announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

Grand Challenges Canada announces 15 grants to support rising stars in global health

Grand Challenges Canada today announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions.

10 Feb 2012

Prestige Brands third quarter net revenues increase 17.3% to $106.3M

Prestige Brands Holdings, Inc. today announced results for the fiscal 2012 third quarter ended December 31, 2011, including net revenues of $106.3 million, an increase of 17.3% over the prior year's comparable quarter of $90.6 million.

9 Feb 2012

NewsOne examines HIV in Caribbean

NewsOne examines HIV in the Caribbean, where one percent of the population is infected with the virus, "small in comparison to numbers found in the global scheme but significant enough to distinguish it as the second-highest region with HIV/AIDS outside of sub-Saharan Africa."

9 Feb 2012

Examining debate over bird flu research

In this post on KPLU's "Humanosphere" blog, journalist Tom Paulson describes "five reasons why you should not panic" about the recent news that two research teams have created bird flu strains that are easily transmissible among ferrets, which are used as a lab model for humans.

9 Feb 2012

South Asian nations explore ways to strengthen collaboration at forum for health research

Delegates and officials from Bangladesh, Bhutan, Nepal, Pakistan, Sri Lanka, Maldives, and Thailand representing their health and medical research councils on Tuesday in New Delhi concluded a three-day South Asian Forum for Health Research (SAHFer) hosted by the Indian Council of Medical Research (ICMR), Pharmabiz.com reports.

9 Feb 2012

Four options for resolving bird flu research debate

In this Scientific American opinion piece, author and former staff writer at Scientific American John Horgan examines "a bitter debate" among scientists over the publication of controversial H5N1 research, writing, "Research involving the bird-flu virus H5N1 poses an especially knotty dilemma, in which scientists' commitment to openness -- and to reducing humanity's vulnerability to potential health threats -- collides with broader security concerns."

8 Feb 2012

New technologies safe and effective for fat removal

For many people, getting rid of excess fat can be a lifelong battle. Whether it is undesirable love handles, excess fat around the knees or flabby upper arms, pockets of fat can be difficult to reduce and sometimes diet and exercise are not enough to make a noticeable difference. Now, dermatologists are finding that the introduction of non-invasive fat removal technologies is opening the door for more people who are not candidates for liposuction to remove stubborn fat, safely and effectively.

8 Feb 2012

GSK launches Medivir's Xerclear for OTC use in Europe

Medivir AB, the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.

8 Feb 2012